XML 37 R26.htm IDEA: XBRL DOCUMENT
v3.26.1

Share capital (Tables) | 6 Months Ended
--- | ---
Jun. 30, 2026
Stockholders' Equity Note [Abstract] |
Schedule of assumptions used to estimate the fair value of warrants [Table Text Block] |
|  | Issue Date March 10, 2025 |
Valuation date share price | $ | 3.40 |
Exercise price | $ | 2.80 |
Dividend yield |  | - |
Risk-free interest rate |  | 3.98% |
Expected warrant life |  | 5.00 years |
Expected volatility |  | 97.81% |
Schedule of warrants continuity outstanding and exercisable [Table Text Block] |
|  | Number of common share warrants outstanding |  |  | Weighted average exercise price $ |  |  | Weighted average remaining life (years) |
Outstanding as at December 31, 2025 |  | 7,281,795 |  |  | 2.70 |  |  | 4.90 |
Warrants granted |  | - |  |  | - |  |  | - |
Warrants exercised |  | - |  |  | - |  |  | - |
Total Warrants outstanding as at June 30, 2026 |  | 7,281,795 |  |  | 2.70 |  |  | 4.41 |
Schedule of warrants outstanding [Table Text Block] |
| Warrants outstanding
| Expiry date | Exercise price | Number outstanding | Number exercisable
Warrants issued as part of the IPO | November 15, 2029 | $ 4.64 | 985,595 | 985,595
Regulation A Warrants | March 10, 2030 | $ 2.80 | 16,200 | 16,200
June 30, 2030 Warrants | June 2, 2030 | $ 3.10 | 2,260,000 | 2,260,000
Series C and D Warrants | June 5, 2031 | $ 2.00 | 4,020,000 | 4,020,000

X
- Definition Tabular disclosure of information about the warrants continuity outstanding and exercisable. + References No definition available. + Details
Name: | mdcx_ScheduleOfWarrantsContinuityOutstandingAndExercisableTableTextBlock
Namespace Prefix: | mdcx_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of input and valuation technique used to measure fair value and change in valuation approach and technique for each separate class of asset and liability measured on recurring and nonrecurring basis. + References Reference 1: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(1) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 Reference 2: http://www.xbrl.org/2003/role/exampleRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 55 -Paragraph 103 -Publisher FASB -URI https://asc.fasb.org/1943274/2147482078/820-10-55-103 Reference 3: http://www.xbrl.org/2003/role/disclosureRef -Topic 820 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 2 -Subparagraph (bbb)(2) -Publisher FASB -URI https://asc.fasb.org/1943274/2147482106/820-10-50-2 + Details
Name: | us-gaap_FairValueAssetsAndLiabilitiesMeasuredOnRecurringAndNonrecurringBasisValuationTechniquesTableTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of warrants or rights issued. Warrants and rights outstanding are derivative securities that give the holder the right to purchase securities (usually equity) from the issuer at a specific price within a certain time frame. Warrants are often included in a new debt issue to entice investors by a higher return potential. The main difference between warrants and call options is that warrants are issued and guaranteed by the company, whereas options are exchange instruments and are not issued by the company. Also, the lifetime of a warrant is often measured in years, while the lifetime of a typical option is measured in months. Disclose the title of issue of securities called for by warrants and rights outstanding, the aggregate amount of securities called for by warrants and rights outstanding, the date from which the warrants or rights are exercisable, and the price at which the warrant or right is exercisable. + References Reference 1: http://www.xbrl.org/2009/role/commonPracticeRef -Topic 505 -SubTopic 10 -Name Accounting Standards Codification -Section 50 -Paragraph 3 -Publisher FASB -URI https://asc.fasb.org/1943274/2147481112/505-10-50-3 + Details
Name: | us-gaap_ScheduleOfStockholdersEquityNoteWarrantsOrRightsTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_StockholdersEquityNoteAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration